Breaking News Bar
updated: 12/7/2012 4:57 PM

FDA panel opposes pure hydrocodone painkiller

hello
Success - Article sent! close
 
Associated Press

WASHINGTON -- Government health experts overwhelmingly voted against a stronger version of hydrocodone, the powerful painkiller that is among the most widely abused medications in the U.S.

The Food and Drug Administration's panel of pain specialists voted 11-2 with one abstention against Zohydro for moderate to severe chronic pain. The drug was developed as a long-acting pain reliever by San Diego-based Zogenix Inc.

Order Reprint Print Article
 
Interested in reusing this article?
Custom reprints are a powerful and strategic way to share your article with customers, employees and prospects.
The YGS Group provides digital and printed reprint services for Daily Herald. Complete the form to the right and a reprint consultant will contact you to discuss how you can reuse this article.
Need more information about reprints? Visit our Reprints Section for more details.

Contact information ( * required )

Success - request sent close

The FDA is not required to follow the group's recommendation, though it often does so.

If approved, Zohydro would be the first pure hydrocodone medication approved in the U.S. Existing products combine the drug with lower-strength painkillers such as acetaminophen.

Hydrocodone is prescribed to treat pain from injuries, surgery, arthritis, migraines and a variety of other ailments.

Share this page
Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.
    help here